Cresco Labs Inc. (CRLBF) Net Income towards Common Stockholders (2020 - 2026)

Cresco Labs (CRLBF) has reported Net Income towards Common Stockholders for 7 consecutive years, with $16.8 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Net Income towards Common Stockholders rose 202.83% year-over-year to $16.8 million; the trailing twelve-month figure through Jun 2026 stood at $169.5 million (up 62.08% YoY), and the FY2025 full-year result was $135.4 million, up 79.3% from the prior year.
• Net Income towards Common Stockholders climbed to $16.8 million in Q2 2026 per CRLBF's latest filing, from -$13.3 million in the prior quarter.
• Across five years, Net Income towards Common Stockholders topped out at $353.7 million in Q4 2023 and bottomed at -$115.6 million in Q3 2023.
• Historically, Net Income towards Common Stockholders has averaged $33.4 million across 5 years, with a median of -$13.4 million in 2022.
• The sharpest annual moves came in 2023 and 2026: Net Income towards Common Stockholders sank 1080.75% in 2023, then surged 202.83% in 2026.
• Over 5 years, Net Income towards Common Stockholders stood at $262.8 million in 2022, then surged by 34.6% to $353.7 million in 2023, then plunged by 58.76% to $145.9 million in 2024, then climbed by 25.62% to $183.2 million in 2025, then tumbled by 90.83% to $16.8 million in 2026.
• According to Business Quant data, Net Income towards Common Stockholders over the past three periods registered $16.8 million, -$13.3 million, and $183.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.